🇺🇸 FDA
Patent

US 12156864

Analogs of cyclobenzaprine and amitryptilene

granted A61KA61K31/135A61K31/155

Quick answer

US patent 12156864 (Analogs of cyclobenzaprine and amitryptilene) held by TONIX PHARMACEUTICALS HOLDING CORP expires Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TONIX PHARMACEUTICALS HOLDING CORP
Grant date
Tue Dec 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/135, A61K31/155, A61K31/397, A61K45/06